HealthFDA’s safety review of the main abortion pill to continue into next year
The U.S. Food and Drug Administration says its ongoing safety review of the country’s main abortion pill will extend into next year. Abortion opponents seeking to curb the drug’s use quickly condemned the timeline.
FDA’s safety review of the main abortion pill to continue into next year
